28-Randomised Controlled Trial-YangBF 09.5.12
28-Randomised Controlled Trial-YangBF 09.5.12
28-Randomised Controlled Trial-YangBF 09.5.12
Descriptive epidemiology
Analytical epidemiology
Example:
Multi-centre trials
Studying subjects at more than one site
Drawbacks:
(1)publication bias: postive outcome more likely to be
published.
(2)quality of studies, quality of life and cost-
effectiveness are not normally evaluated
Eligibility criteria:
patients who are most likely to benefit
from the treatment
they will not represent the whole population
of patients
Treaty of Helsinke
IRB approval
Informed consent
Subjects
confidence intervals.